Hematology/Oncology Topics
RSSArticles
Sickle Cell Disease in the Emergency Department
Sickle cell disease is a complex condition with diverse potential complications. In the emergency department setting, physicians should be aware of the life-threatening pathologies that can affect patients with sickle cell disease.
Momelotinib Tablets (Ojjaara)
Momelotinib can be prescribed to treat intermediate- or high-risk myelofibrosis.
Pediatric Hematology/Oncology Trainees Want Ethics Expertise
Ethics education would not replace the option or need to obtain a formal ethics consultation. However, such education could lead to fewer cases during which specialists believe they need such assistance.
Physician Group Says to Start Colon Cancer Screening at Age 50 Years
Patient advocates push back, standing by other recommendations that set the age at 45 years.
Reconsidering Aspirin Therapy for Elderly Patients
A post-hoc analysis of the ASPREE trial revealed that in presumably healthy elderly subjects, taking low-dose aspirin daily over three years was associated with a significant drop in hemoglobin and ferritin levels vs. placebo, even when patients with major bleeding events were excluded.
U.S. Funding Targets Cancer Rates in Low-Income Neighborhoods
National Cancer Institute to manage a $50 million program to address structural and institutional factors of poverty related to cancer.
Ethical Considerations When Using Gene-Editing Treatment for Sickle Cell Disease
Like any other treatment, it is important patients are aware of limitations, but without crushing their hopes that a cure might be feasible.
Advance Care Planning Can Lower Odds of Aggressive End-of-Life Treatment
Advance care planning was associated with significantly lower odds of indicators of aggressive end-of-life care (i.e., hospital death, hospital admissions, intensive care, delayed hospice referrals, and chemotherapy). Cancer patients who engaged in advance care planning were 50% more likely to complete Do Not Resuscitate orders compared to cancer patients without an advance directive.
EPA Moving to Reduce Cancer Risk to HCWs Exposed to EtO Sterilant
Ethylene oxide (EtO) is used on approximately 50% of all sterilized medical devices annually, including an estimated 95% of all surgical kits. EtO can sterilize heat- or moisture-sensitive medical equipment without causing any damage. Proposed regulations from the Environmental Protection Agency are designed to sharply reduce worker exposures to EtO sterilant and prevent occupational cancer.
Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (Altuviiio)
Altuviiio can be prescribed to adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes, and perioperative bleeding management.